Liu Z - Search Results

1

Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids.

Li K, Hu X, Tu XY, Xian MY, Huang LL, Huang T, Luo R, Jin H, Liu Z. Li K, et al. Among authors: liu z. J Med Chem. 2024 Dec 26;67(24):21916-21933. doi: 10.1021/acs.jmedchem.4c01801. Epub 2024 Dec 9. J Med Chem. 2024. PMID: 39648985

2

Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine.

Hu X, Xian MY, Wang XF, Zou GQ, Luo R, Peng H, Liu Z. Hu X, et al. Among authors: liu z. ACS Med Chem Lett. 2023 Nov 20;14(12):1647-1655. doi: 10.1021/acsmedchemlett.3c00154. eCollection 2023 Dec 14. ACS Med Chem Lett. 2023. PMID: 38116441 Free PMC article.

3

Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist.

Wang XF, Zhang MJ, He N, Wang YC, Yan C, Chen XZ, Gao XF, Guo J, Luo R, Liu Z. Wang XF, et al. Among authors: liu z. J Med Chem. 2021 Aug 12;64(15):11554-11569. doi: 10.1021/acs.jmedchem.1c00881. Epub 2021 Jul 19. J Med Chem. 2021. PMID: 34279930

4

iNKT cell agonists as vaccine adjuvants to combat infectious diseases.

Li YQ, Yan C, Luo R, Liu Z. Li YQ, et al. Among authors: liu z. Carbohydr Res. 2022 Mar;513:108527. doi: 10.1016/j.carres.2022.108527. Epub 2022 Feb 23. Carbohydr Res. 2022. PMID: 35240551

5

A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses.

Li YQ, Yan C, Wang XF, Xian MY, Zou GQ, Gao XF, Luo R, Liu Z. Li YQ, et al. Among authors: liu z. ACS Infect Dis. 2022 Oct 14;8(10):2161-2170. doi: 10.1021/acsinfecdis.2c00296. Epub 2022 Aug 31. ACS Infect Dis. 2022. PMID: 36043698

6

Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity.

Zou GQ, Li K, Yan C, Li YQ, Xian MY, Hu X, Luo R, Liu Z. Zou GQ, et al. Among authors: liu z. Vaccine. 2024 Aug 30;42(21):126145. doi: 10.1016/j.vaccine.2024.07.046. Epub 2024 Jul 20. Vaccine. 2024. PMID: 39034218

7

Development of a Genetically Engineered Bivalent Vaccine against Porcine Epidemic Diarrhea Virus and Porcine Rotavirus.

Li W, Lei M, Li Z, Li H, Liu Z, He Q, Luo R. Li W, et al. Among authors: liu z. Viruses. 2022 Aug 9;14(8):1746. doi: 10.3390/v14081746. Viruses. 2022. PMID: 36016368 Free PMC article.

8

Construction of a Recombinant Porcine Epidemic Diarrhea Virus Encoding Nanoluciferase for High-Throughput Screening of Natural Antiviral Products.

Li W, Zhang M, Zheng H, Zhou P, Liu Z, Jongkaewwattana A, Luo R, He Q. Li W, et al. Among authors: liu z. Viruses. 2021 Sep 18;13(9):1866. doi: 10.3390/v13091866. Viruses. 2021. PMID: 34578449 Free PMC article.

9

Synthesis and Evaluation of Liposomal Anti-GM3 Cancer Vaccine Candidates Covalently and Noncovalently Adjuvanted by αGalCer.

Yin XG, Lu J, Wang J, Zhang RY, Wang XF, Liao CM, Liu XP, Liu Z, Guo J. Yin XG, et al. Among authors: liu z, liu xp. J Med Chem. 2021 Feb 25;64(4):1951-1965. doi: 10.1021/acs.jmedchem.0c01186. Epub 2021 Feb 4. J Med Chem. 2021. PMID: 33539088

10

Structure-Guided Design of Affinity/Covalent-Bond Dual-Driven Inhibitors Targeting the AMP Site of FBPase.

Cao H, Huang Z, Liu Z, Zhang X, Ren Y, Hameed MS, Rao L, Makunga NP, Dobrikov GM, Wan J. Cao H, et al. Among authors: liu z. J Med Chem. 2024 Nov 28;67(22):20421-20437. doi: 10.1021/acs.jmedchem.4c01886. Epub 2024 Nov 9. J Med Chem. 2024. PMID: 39520680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,620 results

Search Page

Filters